Evidence map›Paper›PMID 41082020›Full record

ArticleScience and engineering ethics2025

From Nano to Quantum: Ethics Through a Lens of Continuity.

Clare Shelley-Egan, Eline De Jong

Abstract read
In one paragraph

Article in Science and engineering ethics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Clare Shelley-EganEthics and Philosophy of Technology Section, Department of Values, Technology and Innovation, Faculty of Technology, Policy and Management, Jaffalaan 5, Delft, 2628 BX, The Netherlands. c.shelley-egan@tudelft.nl.
Eline De JongLanguage and Computation, Institute of Physics, University of Amsterdam: Institute for Logic, QuSoft Stanford Center for Responsible Quantum Technology, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A significant amount of scholarship and funding has been dedicated to ethical and social studies of new and emerging science and technology (NEST), from nanotechnology to synthetic biology, and Artificial Intelligence. Quantum technologies comprise the latest NEST attracting interest from scholarship in the social sciences and humanities. While there is a small community now emerging around broader discussion of quantum technologies in society, the concepts of ethics of quantum technologies and responsible innovation are still fluid. In this article, we argue that lessons from previous instances of NEST can offer important insights into the early stages of quantum technology discourse and development. In the embryonic stages of discourse around NEST, there is often an undue emphasis on the novelty of ethical issues, leading to speculation and misplaced resources and energy. Using a lens of continuity, we revisit experiences and lessons from nanotechnology discourse. Zooming in on key characteristics of the nanoethics discourse, we use these features as analytical tools with which to assess and analyse emerging discourse around quantum technologies. We point to continuities between nano and quantum discourse, including the focus on 'responsible' or 'good' technology; the intensification of ethical issues brought about by enabling technologies; the limitations and risks of speculative ethics; the effects of ambivalence on the framing of ethics; and the importance of paying attention to the present. These issues are taken forward to avoid 'reinventing the wheel' and to offer guidance in shaping the ethics discourse around quantum technologies into a more focused and effective debate.

Indexed as

NanotechnologyQuantum TheoryScienceTechnologyArtificial IntelligenceHumansSynthetic BiologyContinuityNanoethicsNEST-ethicsQuantum ethicsQuantum for goodQuantum technologies

Identifiers

PMID41082020
PMCPMC12518464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.